Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
10/2005
10/06/2005US20050222129 Non-imidazole heterocyclic compounds
10/06/2005US20050221989 O-cyclopropyl-carboxanilides and their use as fungicides
10/06/2005DE102004014620A1 2,4,6-phenylsubstituierte cyclische Ketoenole 2,4,6-substituted cyclic ketoenols
10/06/2005DE102004012751A1 Verwendung von N-Ethyl-2-pyrrolidon Use of N-ethyl-2-pyrrolidone
10/06/2005CA2666359A1 Process for the production of atorvastatin calcium in amorphous form
10/06/2005CA2627940A1 Process for the production of atorvastatin calcium in amorphous form
10/06/2005CA2561076A1 2,4,6-phenylsubstituted cyclic ketoenoles
10/06/2005CA2561057A1 Prolinyl derivatives for treating thrombosis
10/05/2005EP1582514A1 Processes for producing glutamic acid derivative and pyroglutamic acid derivative and novel intermediate for production
10/05/2005EP1581511A1 Ccr8 inhibitors
10/05/2005EP1581496A2 2-substituted-3-propenamide derivatives and methods of using the same
10/05/2005EP1581490A1 Substituted 5-aminomethyl-1h-pyrrole-2-carboxamides
10/05/2005EP1581489A2 Compounds having prolyl oligopeptidase inhibitory activity
10/05/2005EP1581488A1 Inhibitors of tace
10/05/2005EP1581487A2 Methods and compounds producing dipeptidyl peptidase iv inhibitors and intermediates thereof
10/05/2005EP1581476A2 Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors
10/05/2005EP1226107B1 N-benzyl-p-phenylenediamine-derivatives containing colouring agents for keratin fibres and novel n-benzyl-p-phenylenediamine-derivatives
10/05/2005EP0775110B1 Arylthio compounds as antibacterial and antiviral agents
10/05/2005CN1678591A New carboxamide compounds having melanin concentrating hormone antagonistic activity, pharmaceutical preparations comprising these compounds and process for their manufacture
10/05/2005CN1678577A HMG-COA reductase inhibitors
10/05/2005CN1678576A Pyrrolidine derivatives as oxytocin antagonists
10/05/2005CN1678575A Benzenesulfonate of 4-fluoro-2-cyanopyrrolidine derivative
10/05/2005CN1678573A Diarylurea derivatives and their use as chloride channel blockers
10/05/2005CN1676515A 3-acyl-pyrrolidine-2, 4-diketo compound and herbicidal activity
10/05/2005CN1221532C Pyrrolcarboxamides and pyrrolcarbothioamides and their agrochemical uses
10/05/2005CN1221529C Substituted N-[(aminoiminomethyl or aminomethyl) phenyl] propyl amides
10/05/2005CN1221524C Diphenyl ether compounds useful in therapy
10/05/2005CN1221514C Intermediate for preparing alkyl-dihalogeno phenyl substituted keto-enol
10/04/2005US6951951 Antitumor agents
10/04/2005US6951886 Succinoylamino hydroxyethylamino sulfonyl urea derivatives useful as retroviral protease inhibitors
10/04/2005US6951878 Benzo[b]thiophenyl or tetrahydro-benzo[b]thiophenyl modulators of protein tyrosine phosphatases (PTPases)
10/04/2005US6951877 Materials and methods for treating hypercholesterolemia
10/04/2005US6951874 Compounds
10/04/2005CA2094397C Homobifunctional agents for coupling enzymes and the like to antibodies and the like
09/2005
09/29/2005WO2005090447A2 Use of n-ethyl-2-pyrrolidone
09/29/2005WO2005090347A1 Aryl and heteroaryl-piperidinecarboxylate derivatives, the preparation and the use thereof in the form of faah enzyme inhibitors
09/29/2005WO2005090301A1 Crystalline form of atorvastatin hemi calcium
09/29/2005WO2005090300A1 Novel benzyl(idene)-lactam derivatives
09/29/2005WO2005090298A1 Sulphonamide derivatives
09/29/2005WO2005090297A1 Sulphonamide derivatives
09/29/2005WO2005090294A2 PROCESS OF MAKING α-AMINOOXYKETONE/α-AMINOOXYALDEHYDE AND α-HYDROXYKETONE/α-HYDROXYALDEHYDE COMPOUNDS AND A PROCESS OF MAKING REACTION PRODUCTS FROM CYCLIC α,ß-UNSATURATED KETONE SUBSTRATES AND NITROSO SUBSTRATES
09/29/2005WO2005090284A1 Non-glycosylated/non-glycosidic/non-peptidic small molecule psgl-1 mimetics for the treatment of inflammatory disorders
09/29/2005WO2005090283A1 Methods of amination
09/29/2005WO2005090282A1 Androgen receptor modulator compounds and methods
09/29/2005WO2005089760A1 8-hydroxy-5-[(-hydroxy-2-[[ (1r)-2-(4-methoxyphenyl)-1-methylethyl] amino ][ethyl] -2(1h)-quinolinone monohydrochloride in crystalline form and the process for its preparation
09/29/2005WO2005089759A1 Derivatives of piperidinylalkylcarbamates, preparation method thereof and use of same as faah enzyme inhibitors
09/29/2005WO2005073195A3 Hcv ns-3 serine protease inhibitors
09/29/2005WO2004106299A8 Substituted pyrrole derivatives and their use as hmg-co inhibitors
09/29/2005US20050215799 reacting aryl/heteroaryl triflate/halide with carbon monoxide and N-hydroxysuccinimide in solvent in presence of palladium catalyst and base
09/29/2005US20050215794 Group IB compounds used as condensation, amination, amidation or arylation catalysts; catalysis; efficiency; forming a carbon-carbon bond between a reactant comprising a nucleophilic carbon atom, e.g., enolate or malonate anion, and activated carbon of an aryl, heteroaryl, or vinyl halide or sulfonate
09/29/2005US20050215784 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
09/29/2005US20050215772 Furanone derivatives and methods of making same
09/29/2005US20050215771 heterobifunctional maleimides allowing the attachment of molecules on their surfaces used for in vitro diagnosis of diseases involving recognition of ligand-antiligand pairs
09/29/2005US20050215637 Tuberculosis treatment
09/29/2005US20050215609 Novel uses of prostaglandin d2, prostaglandin d2 agonist and prostaglandin d2 antagonist
09/29/2005US20050215599 Pyrrolidine-3,4-dicarboxamide derivatives
09/29/2005US20050215593 Kaposi's sarcoma; Crohn's disease
09/29/2005US20050214853 Methods of screening agents, conjugates or conjugate moieties for transport by a PEPT2 transporter
09/29/2005US20050214249 Release nitric oxide under physiological conditions and are useful for treating biological disorders
09/29/2005DE102004010943A1 Verfahren zur Herstellung von N-geschützten 4-Ketprolinderivaten Process for the preparation of N-protected 4-Ketprolinderivaten
09/29/2005CA2560650A1 8-hydroxy-5-[(1r)-1-hydroxy-2-[[(1r)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]-2(1h)-quinolinone monohydrochloride in crystalline form and the process for its preparation
09/29/2005CA2560282A1 Crystalline form of atorvastatin hemi calcium
09/29/2005CA2559919A1 Sulphonamide derivatives
09/29/2005CA2554610A1 Aryl and heteroaryl-piperidinecarboxylate derivatives, the preparation and the use thereof in the form of faah enzyme inhibitors
09/29/2005CA2554608A1 Derivatives of piperidinylalkylcarbamates, preparation method thereof and use of same as faah enzyme inhibitors
09/28/2005EP1580185A1 Secondary n-Alkylhydroxylated p-Phenylendiamins, dye composition for keratin fibers containing them, processes and uses.
09/28/2005EP1578725A1 Microsomal triglyceride transfer protein inhibitors
09/28/2005EP1578417A1 1,5-diaryl-pyrrole-3-carboxamide derivatives and their use as cannabinoid receptor modulators
09/28/2005EP1578414A2 Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
09/28/2005EP1578413A2 Ace-inhibitors having antioxidant and no-donor activity
09/28/2005EP1448521B1 Derivatives of andrimide and moiramide b having antibacterial properties
09/28/2005EP1165510B1 1-arenesulfonyl-2-aryl-pyrrolidine and piperidine derivatives for the treatment of cns disorders
09/28/2005EP1037875B1 Method for producing salts of cyclic amidines
09/28/2005EP0963200B1 Compositions for inhibition of angiogenesis comprising thalodomide and a nsaid
09/28/2005CN1675200A Process for preparing 5-(4-fluorophenyl)-1-[2-((2r, 4r)-4-hydroxy -6-oxo-tetrahydro-pyran-2-yl)ethyl]-2-isopropyl-4-phenyl-1h-pyrrole-3-carboxylic acid phenylamide
09/28/2005CN1674906A 有丝分裂驱动蛋白抑制剂 Mitotic kinesin inhibitors
09/28/2005CN1220695C Inhibitors of nucleoside metabolism
09/28/2005CN1220679C Preparation of thiol carbamate and thiocyanic ester compound
09/27/2005US6949678 For resist applications; thermostability, storage stability
09/27/2005US6949662 Cis-substituted aminocyclopropane derivative
09/27/2005US6949661 3-substituted-3-(substitutedsulfonyl or sulfanyl) pyrrolidine-2,5-diones useful for inhibition of farnesyl-protein transferase
09/27/2005US6949585 Cytokine antagonist; immunology, viricides, antitumor agents, anticancer agents
09/27/2005US6949570 Carboxyalkyl substituted sulfonamidomethyl amides or ureas used for treatment of inflammatory diseases in a mammalian patient, e.g., human, such as asthma, Alzheimer's disease, atherosclerosis, AIDS dementia, and diabetes
09/27/2005US6949553 Aliphatic compounds, their synthesis method, and utilization of the same
09/27/2005US6949537 LY294002 and analogs thereof comprising a reversibly quaternized amine; use of the pro-compounds for treatment of a condition associated with PI-3 kinase activity, including inflammatory disease, age-related macular degeneration, hypertension
09/27/2005US6949534 An amide compound containing a very late antigen of activation-4 (VLA-4) specifity determinanat which doesn't impart significant IIb/IIIa activity; antiinflammatory agent and useful for treating autoimmune disorders
09/27/2005US6949341 Diagnosing genetic disorders
09/22/2005WO2005087763A1 Diphenylmethyl compounds useful as muscarinic receptor antagonists
09/22/2005WO2005087751A2 Substituted hydroxyethylamine aspartyl protease inhibitors
09/22/2005WO2005087724A2 Sulphonylpyrroles as hdac inhibitors
09/22/2005WO2005087723A1 An improved preparation of atorvastatin
09/22/2005WO2005087722A1 Diphenylmethyl compounds useful as muscarinic receptor antagonists
09/22/2005WO2005087710A1 Aminophenylpropanoic acid derivative
09/22/2005WO2005087700A2 Bisphenyl compounds useful as vitamin d3 receptor agonists
09/22/2005WO2005087236A1 Novel m3 muscarinic acetylcholine receptor antagonists
09/22/2005WO2005087235A1 Pyrrolidine compounds
09/22/2005WO2005087215A1 Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors
09/22/2005WO2005016876A3 Cyclic amine bace-1 inhibitors having a benzamide substituent
09/22/2005WO2005004802A3 N-alkyl phenylcarboxamide beta-secretase inhibitors for the treatment of alzheimer's disease
09/22/2005US20050209466 Reproducible; avoids use of 3-pyrrolidinol as a starting material
1 ... 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 ... 404